Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis

被引：0
|
作者：
Axelsson, M. [1 ]
Malmestrom, C. [1 ]
Gunnarsson, M. [2 ]
Zetterberg, H. [1 ]
Sundstrom, P. [3 ]
Lycke, J. [1 ]
Svenningsson, A. [3 ]
机构：
[1] Univ Gothenburg, Gothenburg, Sweden
[2] Orebro Univ Hosp, Orebro, Sweden
[3] Umea Univ, Umea, Sweden
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：543 / 543
页数：1
相关论文
共 50 条
  • [31] Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis
    James M. Stankiewicz
    Hadar Kolb
    Arnon Karni
    Howard L. Weiner
    Neurotherapeutics, 2013, 10 : 77 - 88
  • [32] Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis
    Stankiewicz, James M.
    Kolb, Hadar
    Karni, Arnon
    Weiner, Howard L.
    NEUROTHERAPEUTICS, 2013, 10 (01) : 77 - 88
  • [33] Challenge of progressive multiple sclerosis therapy
    Thompson, Alan J.
    CURRENT OPINION IN NEUROLOGY, 2017, 30 (03) : 237 - 240
  • [34] Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis
    Recks, Mascha S.
    Stormanns, Eva R.
    Bader, Jonas
    Arnhold, Stefan
    Addicks, Klaus
    Kuerten, Stefanie
    CLINICAL IMMUNOLOGY, 2013, 149 (01) : 32 - 45
  • [35] CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage
    Christensen, Jeppe Romme
    Komori, Mika
    von Essen, Marina Rode
    Ratzer, Rikke
    Bornsen, Lars
    Bielekova, Bibi
    Sellebjerg, Finn
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (07) : 937 - 946
  • [36] Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis
    Basso, Alexandre S.
    Frenkel, Dan
    Quintana, Francisco J.
    Costa-Pinto, Frederico A.
    Petrovic-Stojkovic, Sanja
    Puckett, Lindsay
    Monsonego, Alon
    Bar-Shir, Amnon
    Engel, Yon
    Gozin, Michael
    Weiner, Howard L.
    JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (04): : 1532 - 1543
  • [37] Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
    Gunnarsson, Martin
    Malmestrom, Clas
    Axelsson, Markus
    Sundstrom, Peter
    Dahle, Charlotte
    Vrethem, Magnus
    Olsson, Tomas
    Piehl, Fredrik
    Norgren, Niklas
    Rosengren, Lars
    Svenningsson, Anders
    Lycke, Jan
    ANNALS OF NEUROLOGY, 2011, 69 (01) : 83 - 89
  • [38] Axonal Damage and its Significance for the Concept of Neurodegeneration in Multiple Sclerosis
    Recks, M. S.
    Bader, J.
    Kaiser, C. C.
    Schroeter, M.
    Fink, G. R.
    Addicks, K.
    Kuerten, S.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2011, 79 (03) : 161 - 170
  • [39] Fibrinogen identified as having a role in axonal damage in multiple sclerosis
    Nowak, Madeleine
    EXPERT REVIEW OF PROTEOMICS, 2013, 10 (01) : 11 - 11
  • [40] The relationship between diffuse axonal damage and fatigue in multiple sclerosis
    Tartaglia, MC
    Narayanan, S
    Francis, SJ
    Santos, AC
    De Stefano, N
    Lapierre, Y
    Arnold, DL
    ARCHIVES OF NEUROLOGY, 2004, 61 (02) : 201 - 207
12345